Vesugen (KED)
Vesugen is a synthetic short-chain peptide composed of three amino acids: lysine, glutamic acid, and aspartic acid. Its peptide sequence is commonly abbreviated as Lys–Glu–Asp or KED.
Vesugen is investigated in controlled laboratory settings for its potential interactions with vascular endothelial cells, cellular proliferation markers, gene-expression pathways, and age-associated changes in cellular function. Its compact tripeptide structure also makes it a compound of interest for researchers studying tissue-specific peptide signaling and peptide structure–activity relationships.
At biozone peptides, Vesugen is supplied exclusively as a research material for qualified laboratory and analytical applications.
Research Areas
Vascular endothelial cell research
Cellular proliferation and differentiation models
Age-associated cellular changes
Gene-expression pathway research
Short-chain peptide signaling
Peptide structure–activity analysis
Product Information
Product name: Vesugen
Alternative name: KED peptide
Peptide sequence: Lys–Glu–Asp
Classification: Synthetic tripeptide research material
Form: Lyophilized powder
Storage and Handling
Store according to the conditions stated on the product label or accompanying testing documentation. Handle only in an appropriate laboratory environment using established research procedures.
Important Research Notice
This product is intended strictly for laboratory research purposes only. It is not intended for human or veterinary use, consumption, administration, diagnostic procedures, or therapeutic applications.
Statements regarding this product have not been evaluated by the U.S. Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
⚠️ Research use only. Not medical advice.